Apogem Capital’s Ardelyx ARDX Stock Holding History

Apogem Capital’s Portfolio ARDX Stock Details ARDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-79,142	Closed	-$94K	–	8
2022 Q3	$94K	Sell	79,142 -81,798	-51%	-$77.8K	0.09%	129
2022 Q2	$95K	Buy	+160,940	New	+$119K	0.09%	149

Other funds holding ARDX

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

OCM

Orchard Capital Management Chicago, Illinois $103M AUM 65.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PHS

Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return

Apogem Capital's ARDX Position: Q4 2022 in Review

Apogem Capital sold out of Ardelyx (ARDX) in Q4 2022, closing a stake of 79,142 shares — an estimated $94K sold.

Apogem Capital first reported a position in ARDX in Q2 2022 and held it in 2 quarters. The position peaked at $95K in Q2 2022. 103 funds tracked by Wall St. Rank hold ARDX as of Q4 2022.

Apogem Capital reported no remaining Ardelyx position as of Q4 2022 after selling out during the quarter.
Apogem Capital sold 79,142 Ardelyx shares in Q4 2022, an estimated $94K.
Apogem Capital first reported a position in Ardelyx in Q2 2022 and held it in 2 quarters.
Apogem Capital's Ardelyx position peaked at $95K in Q2 2022.
103 funds tracked by Wall St. Rank held Ardelyx as of Q4 2022.

Based on Apogem Capital's 13F filing for Q4 2022, filed 13 Feb 2023.